The present invention relates to a composition and a combination comprising at least one first drug and at least one protein binding prodrug wherein the proteinbinding prodrug comprises a protein binding group a second drug and a linker that can be cleaved hydrolytically enzymatically or in a pH dependent manner in the body as well as to a kit and a pharmaceutical composition comprising said composition or combination.
